WOLVERINE TRADING, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$281,946
-66.8%
13,700
-24.3%
0.00%
-100.0%
Q2 2023$850,157
+151173.5%
18,100
+35.1%
0.00%0.0%
Q1 2023$562
+10.0%
13,4000.0%0.00%0.0%
Q4 2022$511
-99.9%
13,400
-25.1%
0.00%0.0%
Q3 2022$709,000
+50.2%
17,900
+24.3%
0.00%0.0%
Q2 2022$472,000
+1.9%
14,400
+6.7%
0.00%0.0%
Q1 2022$463,000
-72.1%
13,500
-64.8%
0.00%
-50.0%
Q4 2021$1,659,000
-17.6%
38,363
-15.9%
0.00%0.0%
Q3 2021$2,013,000
-38.9%
45,593
-21.9%
0.00%
-60.0%
Q2 2021$3,292,000
+4.3%
58,381
+35.6%
0.01%0.0%
Q1 2021$3,155,000
-23.6%
43,050
-7.5%
0.01%
-16.7%
Q4 2020$4,127,000
+48.6%
46,551
+0.0%
0.01%
-14.3%
Q3 2020$2,777,000
+47.9%
46,542
+3.6%
0.01%
+40.0%
Q2 2020$1,877,000
-9.1%
44,922
-35.8%
0.01%
-16.7%
Q1 2020$2,065,000
-53.6%
70,000
+40.0%
0.01%
-50.0%
Q4 2018$4,451,000
-31.1%
50,011
+9.3%
0.01%
-20.0%
Q3 2018$6,464,000
-73.2%
45,760
-68.7%
0.02%
-82.8%
Q4 2017$24,097,000
+405.6%
146,298
+91.3%
0.09%
+383.3%
Q3 2017$4,766,000
-17.4%
76,484
+4.7%
0.02%
-33.3%
Q2 2017$5,769,000
+134.0%
73,080
+51.4%
0.03%
+125.0%
Q4 2016$2,465,000
-5.8%
48,280
-16.1%
0.01%0.0%
Q3 2016$2,618,00057,5200.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders